by | Dec 24, 2022 | News
The coronavirus has been a shifty foe, with new variants and subvariants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’ most dangerous traits —...
by | Dec 23, 2022 | News
Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers. The study, published in JAMA Network...
by | Dec 22, 2022 | News
Teenagers and young adults who use benzodiazepines to treat insomnia may be at heightened risk of overdose, a new study finds. Benzodiazepines include anxiety medications like Ativan, Klonopin, Valium and Xanax, as well as prescription sleep aids such as estazolam...
by | Dec 21, 2022 | News
Researchers with the Rutgers Environmental and Occupational Health Sciences Institute have simulated how climate change will affect the distribution of two leading allergens – oak and ragweed pollens – across the contiguous United States. The results, published in the...
by | Dec 21, 2022 | News
Despite the risks to human health, testing for arsenic isn’t required for most private drinking wells in New Jersey. To help address this regulatory gap, a Rutgers researcher developed a machine learning model that can estimate arsenic contamination in private wells...